NHS approach to B12 deficiency: NICE Clinical Knowledge Summaries recommend investigating B12 deficiency in patients presenting with macrocytic anaemia, unexplained neurological symptoms, or risk factors including pernicious anaemia, gastrectomy, malabsorption disorders, metformin use, proton pump inhibitors, or nitrous oxide exposure
Context determines the best choice
The reporting odds ratio for semaglutide was 1.87 for depression and 1.73 for suicide/self-injury events
Helps visibly fade dark spots, improve skin clarity, and smooth uneven texture while neutralizing free radicals
Additionally, despite the profound weight loss, patients experience a numeric elevation of free-fatty acids at the highest dose (420 mg) which declines to baseline during the washout phase [5]
Importantly, this decision applied only to the obesity indicationtirzepatide remains available in its anti-diabetic medication (ADM) formulation (sold as Mounjaro) for patients with type 2 diabetes
